Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Immunological analyses of human papillomavirus capsids
Tzenan Giroglou
, Martin Sapp
, Christopher Lane
, Claudia Fligge
,
Neil Christensen
, Rolf E. Streeck
, Robert C. Rose
Department of Pathology and Laboratory Medicine
Penn State Cancer Institute
Cancer Institute, Mechanisms of Carcinogenesis
Division of Experimental Pathology
Center for Cannabis and Natural Product Pharmaceuticals (CCNPP)
Department of Cell and Biological Systems
Research output
:
Contribution to journal
›
Article
›
peer-review
141
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Immunological analyses of human papillomavirus capsids'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Immunoblot Analysis
100%
Capsid
100%
Virus-like
100%
High-risk Human Papillomavirus (HR-HPV)
100%
HPV16
50%
Epitope
33%
Type-specific
33%
Human Papillomavirus 33
33%
Anogenital
33%
Immune Serum
33%
Pseudovirion
33%
Genotype
16%
Viral
16%
Virus
16%
Genome Sequencing
16%
Enzyme-linked Immunosorbent Assay (ELISA)
16%
Genetic Parameters
16%
Antibody Response
16%
Antiserum
16%
Sequence Relatedness
16%
Virion
16%
Infectivity Assay
16%
B Cells
16%
Human Papillomavirus Types
16%
Polyclonal Antibody
16%
Cross-neutralization
16%
Recombinant Human
16%
Viral Capsid
16%
Virus Genotype
16%
High Titer
16%
Vaccine Candidate
16%
Immunogenic
16%
Antigenic Site
16%
Immunology and Microbiology
Capsid
100%
Virus-Like Particle
100%
Wart Virus
100%
Antiserum
50%
Epitope
33%
Serotype
33%
Vaccine Efficacy
33%
Human Papillomavirus Type 18
33%
Neutralization
33%
Enzyme-Linked Immunosorbent Assay
16%
Titer
16%
Antibody Response
16%
Virion
16%
B Cell
16%
Human Papillomavirus Type 31
16%
Polyclonal Antibody
16%
Human Papillomavirus Type 16
16%
Papillomaviridae
16%
Human Papillomavirus Type 45
16%